🇺🇸 FDA
Patent

US 8686012

Stem cell differentiating agents and uses therefor

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 8686012 (Stem cell differentiating agents and uses therefor) held by The Board of Regents of the University of Texas System expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/42, A61K31/422